Home
>
National Drug Code (NDC)
>
Acarbose
Acarbose - 0378-2820-27 - (acarbose)
Drug Information of Acarbose
| Product NDC: | 0378-2820 |
| Proprietary Name: | Acarbose |
| Non Proprietary Name: | acarbose |
| Active Ingredient(s): | 25 mg/1 & nbsp; acarbose |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Acarbose
| Product NDC: | 0378-2820 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091053 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120917 |
Package Information of Acarbose
| Package NDC: | 0378-2820-27 |
| Package Description: | 270 TABLET in 1 BOTTLE, PLASTIC (0378-2820-27) |
NDC Information of Acarbose
| NDC Code | 0378-2820-27 |
| Proprietary Name | Acarbose |
| Package Description | 270 TABLET in 1 BOTTLE, PLASTIC (0378-2820-27) |
| Product NDC | 0378-2820 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | acarbose |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120917 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | ACARBOSE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] |
